Global Dermatological Drugs Market Size & Outlook, 2025-2030
Global dermatological drugs market, 2018-2030 (US$M)
Related Markets
Global dermatological drugs market highlights
- The global dermatological drugs market generated a revenue of USD 23,858.3 million in 2024 and is expected to reach USD 42,290.8 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 10.1% by 2030.
- In terms of segment, psoriasis accounted for a revenue of USD 9,446.6 million in 2024.
- Psoriasis is the most lucrative therapy segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 23,858.3 million |
| Market revenue in 2030 | USD 42,290.8 million |
| Growth rate | 10.1% (CAGR from 2025 to 2030) |
| Largest segment | Psoriasis |
| Fastest growing segment | Psoriasis |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
Other key industry trends
- In terms of revenue, the North America accounted for 38.7% of the global dermatological drugs market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 2,268.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dermatological Drugs Market Scope
Dermatological Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson Services, Inc. | View profile | - | - | - |
| GALDERMA | View profile | - | - | - |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| Almirall SA | View profile | 1885 | Ronda General Mitre 151, Barcelona, Spain, 08022 | http://www.almirall.es |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global dermatological drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 39.59% in 2024. Horizon Databook has segmented the Global dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Dermatological Drugs Indication Outlook (Revenue, USD Million, 2018-2030)
- Psoriasis
- Atopic Dermatitis (Eczema)
- Fungal infections
- Acne
- Alopecia
- Rosacea
- Others
- Global Dermatological Drugs Type Outlook (Revenue, USD Million, 2018-2030)
- Prescription
- Over-the-Counter (OTC)
- Global Dermatological Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Topical Administration
- Oral Administration
- Parenteral Administration
- Global Dermatological Drugs Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Corticosteroids
- Retinoids
- Antibiotics
- Antifungals
- Calcineurin Inhibitors
- Others
- Global Dermatological Drugs Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacies
- Retail Pharmacies
- Others
Reasons to subscribe to Global dermatological drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global dermatological drugs market databook
-
Our clientele includes a mix of dermatological drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global dermatological drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global dermatological drugs market size, by regions, 2018-2030 (US$M)
Top 10 countries: Dermatological drugs market size, 2024 (US$M)
Global dermatological drugs market share, by indication, 2024 & 2030 (%, US$M)
Dermatological drugs market: Opportunity assessment by country
Global dermatological drugs market, by region, 2024 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
